| 000 | 01728 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514034659.0 | ||
| 264 | 0 | _c20020712 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a0006-2960 | ||
| 024 | 7 |
_a10.1021/bi025720s _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLandwojtowicz, Ewa | |
| 245 | 0 | 0 |
_aReal-time monitoring of P-glycoprotein activation in living cells. _h[electronic resource] |
| 260 |
_bBiochemistry _cJun 2002 |
||
| 300 |
_a8050-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a3T3 Cells |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAdenosine Triphosphatases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiosensing Techniques |
| 650 | 0 | 4 |
_aChloride-Bicarbonate Antiporters _xmetabolism |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aExtracellular Space _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aLLC-PK1 Cells |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aSodium-Hydrogen Exchangers _xmetabolism |
| 650 | 0 | 4 |
_aSubstrate Specificity _xdrug effects |
| 650 | 0 | 4 | _aSwine |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTrifluoperazine _xpharmacology |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _aNervi, Pierluigi | |
| 700 | 1 | _aSeelig, Anna | |
| 773 | 0 |
_tBiochemistry _gvol. 41 _gno. 25 _gp. 8050-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/bi025720s _zAvailable from publisher's website |
| 999 |
_c11964778 _d11964778 |
||